A METHOD FOR PREVENTING COAGULOPATHIC BLEEDING DURING SURGERY FOR MECHANICAL JAUNDICE
Relevance: A pathological syndrome that develops as a result of impaired outflow of hepatic bile through the biliary tract into the intestine due to mechanical obstacles is called mechanical jaundice (MJ). Hemostasis depends on the full function of the liver, since the synthesis of many coagulation factors occurs in liver cells, and activation products occur in cells of the reticuloendothelial system of the liver. Violation of hemostasis directly depends on the severity of hepatocyte dysfunction. Such patients may develop disseminated intravascular coagulation (DIC) and bleeding during and after surgery.
Aim. To improve the results of treatment of coagulopathy bleeding during surgery for mechanical jaundice, through proactive therapy.
Materials and methods. Research design: A non-randomized clinically controlled trial. The state of hemostasis was studied depending on the duration of jaundice in 79 patients with mechanical jaundice treated at the University Hospital of the "Semey Medical University" NCJSC. Inclusion criteria: patients aged 18 and older with obstructive jaundice requiring surgical treatment. Exclusion criteria: children and adolescents under 18 years of age, patients who do not agree to participate, incapacitated, pregnant women. To conduct the study, the patients were divided into 2 groups: the main n = 35 (44.3%) patients who were treated with L-cornitine and the control group n = 44 (55.7%).
For statistical processing, the nonparametric Mann-Whitney criterion was applied when there were restrictions in the use of parametric analysis. To refute the null hypothesis, a statistical significance level of p < 0.05 was adopted.
Results: Changes in blood clotting indices in patients with mechanical jaundice upon admission and on the 1st, 3rd and 5th days after treatment with the proposed method noticeably improve, as there is a shift in the indications of APTT, Klaus fibrinogen, INR and PTT towards hypercoagulation already on the 1st day, (because they they are specific markers of ongoing bleeding).
Conclusion: The proposed improved method for the prevention of coagulopathic bleeding during surgery for mechanical jaundice made it possible to significantly reduce the incidence of coagulopathy in these patients, which is especially important, the frequency of their clinical manifestation, since Klaus fibrinogen in the blood on day 5 was 3,8 g/l, which turned out to be statistically significant U - 412,500 (P =0,05) and the PTT improved on the 5th day was 12,3 seconds, the statistical significance of U - 208,500 (P =0,05).
Meruert T. Orazgalieva1, https://orcid.org/0000-0002-9899-9881
Meyrbek J. Aimagambetov1, https://orcid.org/0000-0003-4699-8200
Nazarbek B. Omarov1, https://orcid.org/0000-0003-3262-1410
Aldiyar E. Masalov1, https://orcid.org/0000-0002-2844-037X
Aynash S. Orazalina1, https://orcid.org/0000-0003-4594-0138
Moldir M. Akbayeva1, https://orcid.org/0000-0002-3616-7000
Zhansaya M. Muratkhanova1, https://orcid.org/0000-0002-6639-8950
Moldir B. Tleubaeva1, https://orcid.org/0000-0002-0424-4163
1 NCJSC “Semey Medical University”, Semey, Republic of Kazakhstan.
1. Андреев Г.Н. Механическая желтуха не опухолевой этиологии. Монография. Великий Новгород - 2004. 123с.
2. Апсатаров Э.А., Оразбеков Н.И. Системные поражения органов гепатобилиарной системы при желчекаменной болезни // Вестник хирургии Казахстана 1996. № 5-6, С. 3-6.
3. Башилов В.П., Брехов Е.И., Малов Ю.Я., Василенко О.Ю. Сравнительная оценка различных методов в лечении больных острым калькулезным холециститом, осложненным холедохолитиазом // Хирургия. 2005. № 10. С. 40-45.
4. Beckingham I.J., Ryder S.D. ABC of diseases of liver, pancreas, and biliary system: Investigation of liver and biliary disease // BMJ. 2011. 322:33-36.
5. Dawson J.L. Preoperative renal function in case of mechanical jaundice; mannitus effect // BMJ. 1965. 1 : 82–6. [Free PMC article] [PubMed] [Google Scholar]
6. Helmke S., Colmenero J., Everson G.T. Noninvasive assessment of liver function // Curr Opin Gastroenterol. 2015 May. 31(3):199-208. doi: 10.1097/MOG.0000000000000167.
7. Navaneethan U., Jayanthi V., Mohan P. Pathogenesis of cholangitis in obstructive jaundice-revisited // Minerva Gastroenterol Dietol. 2011 Mar. 57(1):97-104.
8. Pain J.A., Cahill S.J., Bailey M.E. Perioperative complications of mechanical jaundice: therapeutic considerations // Br J Surg. 1985. 72 : 942–5. [PubMed] [Google Scholar]. PMID: 3936565 DOI: 10.1002/bjs.1800721203.
9. Sookoian S., Pirola C.J. Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicine // World J Gastroenterol. 2015 Jan 21. 21(3):711-25. doi: 10.3748/wjg.v21.i3.711.
References [1-3]:
1. Andreev G.N. Mekhanicheskaya zheltukha ne opukholevoi etiologii. Monografiya. [Mechanical jaundice of non-tumor etiology. Monograph]. Velikii Novgorod. 2004. 123 p. [In Russian]
2. Apsatarov E.A., Orazbekov N.I. Sistemnye porazheniya organov gepatobiliarnoi sistemy pri zhelchekamennoi bolezni [Systemic lesions of the organs of the hepatobiliary system in cholelithiasis]. Vestnik khirurgii Kazakhstana [Bulletin of surgery in Kazahstan]. 1996. № 5-6, pp. 3-6 [In Russian]
3. Bashilov V.P., Brekhov E.I., Malov Yu.Ya., Vasilenko O.Yu. Sravnitel'naya otsenka razlichnykh metodov v lechenii bol'nykh ostrym kal'kuleznym kholetsistitom, oslozhnennym kholedokholitiazom [Comparatively assessment of different methods in treatment of patients with acute calculous cholecystitis, complicated with choledocholytiasis]. Khirurgiya [Surgery]. 2005. № 10. P. 40-45. [In Russian].
Number of Views: 17
Category of articles:
Original articles
Bibliography link
Orazgalieva M.T., Aimagambetov M.J., Omarov N.B., Masalov A.E., Orazalina A.S., Akbayeva M.M., Muratkhanova Zh.M., Tleubaeva M.B. A method for preventing coagulopathic bleeding during surgery for mechanical jaundice // Nauka i Zdravookhranenie [Science & Healthcare]. 2024, (Vol.26) 1, pp. 109-117. doi 10.34689/SH.2024.26.1.014Related publications:
ANALYSIS OF CLINICAL AND DEMOGRAPHIC INDICATORS OF PATIENTS WITH PARKINSON'S DISEASE IN THE SOUTHERN REGION OF KAZAKHSTAN
A COMPARATIVE STUDY OF DRUG POLICY REGARDING ORPHAN DISEASES IN THE USA, THE EUROPEAN UNION, AND THE REPUBLIC OF KAZAKHSTAN
MUTATIONS IN CARDIAC ION CHANNEL GENES IN KAZAKHSTANI PATIENTS WITH LONG QT SYNDROME
GENETIC FEATURES OF CONGENITAL DYSFUNCTION OF THE ADRENAL CORTEX CAUSED BY 21-HYDROXYLASE DEFICIENCY IN PERSONS OF KAZAKH NATIONALITY
NON-MOTOR SYMPTOMS IN PARKINSON'S DISEASE USING THE EXAMPLE OF AKTOBE PATIENTS